abstract |
Novel compounds that inhibit LRRK2 kinase activity, methods for their preparation, compositions containing them, and diseases associated with or characterized by LRRK2 kinase activity, such as Parkinson's disease, Alzheimer's disease and muscle Provided are their use in the treatment or prevention of amyotrophic lateral sclerosis (ALS). |